Health Care Related Organization – Page 19

NFL Legend Jerome Bettis Joins CDC Foundation’s “Live to the Beat” Campaign to Tackle Heart Health in Black Community

4 months ago talkbio0Tagged beat, Bettis, Black Populations, Cardiovascular Diseases, Centers for Disease Control and Prevention (U.S.), Community, Foundations, heart health, Hypertensive disease, Jerome, NEFL gene

Jerome Bettis, CDC Foundation, Live to the Beat, cardiovascular disease, Black community, hypertension, heart health, NFL

Pharmaceutical Giants Bristol Myers Squibb and Kyowa Kirin Announce 119 Layoffs in New Jersey Amid Restructuring Efforts

4 months ago talkbio0Tagged cost-cutting, Drug Industry, Kirin, Kyowa, Myers, New Jersey, restructuring, squibb

Bristol Myers Squibb, Kyowa Kirin, layoffs, New Jersey, restructuring, pharmaceutical industry, cost-cutting, workforce reduction

Novo Nordisk Projects Slower Growth for 2025 Despite Wegovy’s Strong Q4 Performance

4 months ago talkbio0Tagged Drug Industry, Growth, Nordisk, Obesity, Sales - occupational activity, Wegovy

Novo Nordisk, Wegovy, obesity drugs, sales growth, 2025 outlook, pharmaceutical industry

FDA Approves Roche’s Susvimo for Diabetic Macular Edema: A Breakthrough in Continuous Delivery Eye Treatment

4 months ago talkbio0Tagged Approved, Continuous Delivery, dimethylethylsilylimidazole, Macular edema due to diabetes mellitus, Ophthalmological implant, ranibizumab, Roche (company), Susvimo, United States Food and Drug Administration, Vision

Susvimo, ranibizumab, diabetic macular edema, DME, Roche, FDA approval, continuous delivery, eye implant, vision improvement

Bristol Myers Squibb and Kyowa Kirin Announce New Rounds of Layoffs in New Jersey

4 months ago talkbio0Tagged cost-cutting measures, Jersey pharma, Kirin, Kyowa, Myers, Pharmaceutical Layoffs, squibb

Pharmaceutical layoffs, workforce reduction, cost-cutting measures, Bristol Myers Squibb, Kyowa Kirin, New Jersey pharma industry

Pharmaceutical Industry Warns of Drug Shortages and Price Hikes Due to Trump’s New Tariffs

4 months ago talkbio0Tagged Active, APIs, chain disruption, Drug Industry, Drug shortages, Groups, Increased, Prices, TNFRSF19 gene, Trump tariffs

Trump tariffs, drug shortages, price increases, pharmaceutical industry, trade groups, supply chain disruption, generic drugs, active pharmaceutical ingredients (APIs)

Pfizer Exceeds Q4 Expectations: COVID-19 Products and Cost-Cutting Drive Strong Performance

4 months ago talkbio0Tagged Advice, cost-cutting initiatives, COVID19 (disease), earnings, financial recovery, Pfizer, portfolio, revenue growth

Pfizer, Q4 earnings, COVID-19 portfolio, cost-cutting initiatives, revenue growth, Paxlovid, financial recovery, 2025 guidance

Astellas Pharma Announces Major Management Restructuring Amid Strong Financial Performance

4 months ago talkbio0Tagged Administration occupational activities, Astellas Pharma, Drug Industry, financial results, restructuring

Astellas Pharma, management restructuring, financial results, executive appointments, pharmaceutical industry

FDA Approves Roche’s PATHWAY HER2 Test for HER2-Ultralow Metastatic Breast Cancer

4 months ago talkbio0Tagged Approved, Biochemical Pathway, Carcinoma breast stage IV, Diagnosis, Enhertu, erbB-2 Receptor, HER2-ultralow, Pet Animal, Precision Medicine, Roche (company), United States Food and Drug Administration

Roche, PATHWAY HER2 (4B5) test, FDA approval, HER2-ultralow, metastatic breast cancer, companion diagnostic, Enhertu, personalized medicine

CDC Orders Retraction of Research Papers and Removes Website Content Amid New Language Restrictions

4 months ago talkbio0Tagged Centers for Disease Control and Prevention (U.S.), Feeling content, Gender, Languages, LGBTQ+, removal technique, research retraction, restrictions, Scientific Publication, Sense of identity (observable entity), Web Site

CDC, research retraction, website content removal, language restrictions, LGBTQ, gender identity, scientific publications